Mihir Kulkarni

Mihir Kulkarni

Active Director Director DIN 08392252
DIN 08392252 First appointment Mar 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2019
Shareholding value •••• Premium profile

About Mihir Kulkarni

Data last updated:

Mihir Kulkarni is a Director at Saphire Biotech Private Limited (since 2019). The company operates in Pharma. Saphire Biotech Private Limited reported revenue of ₹2.36 Cr (FY 2024).

DIN 08392252
Primary Designation Director
Industry Pharma
First Appointment 30 Mar 2019
Oldest Company Age 21 yrs
Largest company Saphire Biotech Private Limited · ₹2.36 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Saphire Biotech Private Limited U24246MP2004PTC017081
Director30 Mar 20192004₹2.36 Cr (FY 2024)Active

Board colleagues of Mihir Kulkarni

Directorship timeline

Open interactive timeline →
Saphire Biotech Private Limited
Premium access

Shareholding and investment profile for Mihir Kulkarni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mihir Kulkarni

Mihir Kulkarni currently holds 1 directorship: Saphire Biotech Private Limited (Director, since 30 Mar 2019, revenue ₹2.36 Cr (FY 2024)).

Mihir Kulkarni was first appointed on 30 Mar 2019 as Director at Saphire Biotech Private Limited.

The current boards of Mihir Kulkarni's companies include Hemant Kulkarni (Saphire Biotech Private Limited), Ketki Kulkarni (Saphire Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available